AR101274A1 - Composición para uso en la prevención y tratamiento de rinitis alérgica - Google Patents

Composición para uso en la prevención y tratamiento de rinitis alérgica

Info

Publication number
AR101274A1
AR101274A1 ARP150102322A ARP150102322A AR101274A1 AR 101274 A1 AR101274 A1 AR 101274A1 AR P150102322 A ARP150102322 A AR P150102322A AR P150102322 A ARP150102322 A AR P150102322A AR 101274 A1 AR101274 A1 AR 101274A1
Authority
AR
Argentina
Prior art keywords
hydrogenated
composition
prevention
oil
treatment
Prior art date
Application number
ARP150102322A
Other languages
English (en)
Inventor
Lamprecht Jrgen
Panin Giorgio
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51589387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR101274(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Publication of AR101274A1 publication Critical patent/AR101274A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición para aplicación tópica, para uso en la prevención y tratamiento de rinitis alérgica, que consiste en un éster de a-tocoferol seleccionado del grupo que consiste en acetato, n-propionato o linoleato de a-tocoferilo, y un vehiculo oleoso seleccionado del grupo que consiste en poliisobuteno hidrogenado, polideceno hidrogenado, y mezclas de poliisobuteno hidrogenado y/ o polideceno hidrogenado con poliolefinas hidrogenadas, en particular poliolefinas C₆₋₁₄ hidrogenadas, triglicérido caprílico / cáprico, aceite Olus, aceite de Adansonia digitata, aceite de semilla de Adansonia digitata, caprilato / caprato de coco, escualano de oliva, escualeno de oliva, aceite de semilla de girasol (Heliantus annus), caprilato de coco, isononanoato de isononilo, ciclopentasiloxano, y mezclas de los mismos. Reivindicación 8: La composición para el uso de la reivindicación 7, que consiste en 10 - 30% de acetato de a-tocoferilo y 70 - 90% de polideceno hidrogenado.
ARP150102322A 2014-07-22 2015-07-22 Composición para uso en la prevención y tratamiento de rinitis alérgica AR101274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20141332 2014-07-22

Publications (1)

Publication Number Publication Date
AR101274A1 true AR101274A1 (es) 2016-12-07

Family

ID=51589387

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102322A AR101274A1 (es) 2014-07-22 2015-07-22 Composición para uso en la prevención y tratamiento de rinitis alérgica

Country Status (24)

Country Link
US (1) US20170165226A1 (es)
EP (1) EP3171873B1 (es)
CN (1) CN106659709A (es)
AR (1) AR101274A1 (es)
AU (1) AU2015294663B2 (es)
BR (1) BR112017001116A8 (es)
CA (1) CA2955664C (es)
CL (1) CL2017000058A1 (es)
CO (1) CO2017000550A2 (es)
CY (1) CY1122823T1 (es)
DE (1) DE202014106007U1 (es)
DK (1) DK3171873T3 (es)
EA (1) EA201692486A1 (es)
ES (1) ES2779525T3 (es)
HR (1) HRP20200380T1 (es)
HU (1) HUE049588T2 (es)
LT (1) LT3171873T (es)
MX (1) MX369991B (es)
PE (1) PE20170437A1 (es)
PL (1) PL3171873T3 (es)
PT (1) PT3171873T (es)
RS (1) RS60103B1 (es)
SI (1) SI3171873T1 (es)
WO (1) WO2016012110A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9949915B2 (en) 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
DE4327089A1 (de) 1993-08-12 1995-02-16 Roshdy Ismail Mittel zur Behandlung von allergischen Erkrankungen der Atemwege
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
JP2003128552A (ja) 2001-08-16 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
WO2004045556A2 (en) 2002-11-20 2004-06-03 Board Of Regents, The University Of Texas System Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens
JP2008266255A (ja) * 2007-04-24 2008-11-06 Project M:Kk アレルギー性疾患を予防および/または治療するための組成物
US20100076072A1 (en) 2008-07-25 2010-03-25 Northwestern University Compositions and methods of vitamin e administration
IT1393056B1 (it) * 2008-09-22 2012-04-11 Bio Lo Ga Srl Uso di vitamina e o suoi derivati per il controllo di artropodi
ITMI20090480A1 (it) * 2009-03-27 2010-09-28 Bio Lo Ga Srl Supporto tessile imbevuto di una composizione detergente/idratante
BR112013032410A2 (pt) * 2011-06-24 2017-01-17 Epitogenesis Inc composições farmacêuticas compreendendo uma combinação de veículos, vitaminas, taninos e flavonoides de seleção como imunomoduladores específicos de antígeno

Also Published As

Publication number Publication date
PL3171873T3 (pl) 2020-07-13
CN106659709A (zh) 2017-05-10
CA2955664A1 (en) 2016-01-28
LT3171873T (lt) 2020-04-10
CA2955664C (en) 2022-09-06
ES2779525T3 (es) 2020-08-18
CL2017000058A1 (es) 2017-08-11
SI3171873T1 (sl) 2020-07-31
MX369991B (es) 2019-11-27
BR112017001116A2 (pt) 2018-01-23
EA201692486A1 (ru) 2017-07-31
RS60103B1 (sr) 2020-05-29
MX2017000906A (es) 2017-05-12
PT3171873T (pt) 2020-02-25
HRP20200380T1 (hr) 2020-08-07
HUE049588T2 (hu) 2020-10-28
BR112017001116A8 (pt) 2022-07-05
PE20170437A1 (es) 2017-04-22
AU2015294663A1 (en) 2017-01-19
DK3171873T3 (da) 2020-03-16
EP3171873A1 (en) 2017-05-31
AU2015294663B2 (en) 2019-11-21
WO2016012110A1 (en) 2016-01-28
US20170165226A1 (en) 2017-06-15
EP3171873B1 (en) 2019-12-25
CO2017000550A2 (es) 2017-03-31
DE202014106007U1 (de) 2015-07-23
CY1122823T1 (el) 2021-05-05

Similar Documents

Publication Publication Date Title
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
BR112014017716A8 (pt) composições de ésteres de forbol, métodos para prevenir ou tratar acidente vascular cerebral e uso de ésteres de forbol
AR082030A1 (es) Composiciones farmaceuticas topicas que comprenden flurbiprofeno, uso y metodo de tratamiento
AR102973A1 (es) Uso del compuesto 3,5-dihidroxi-4-isopropil-trans-estilbeno para la preparación de una composición farmacéutica, dicho compuesto y composición farmacéutica que lo comprende
CR20190239A (es) Inhibidores de la magl
CO2019002889A2 (es) Tratamientos de combinación que comprenden la administración de imidazopirazinonas
CL2017001073A1 (es) 2,4 diamino-quinolia sustituido como nuevos agentes anticancerigenos
ECSP17011248A (es) Uso de señales visuales para mejorar composiciones repelentes de aves
BR112015023190A2 (pt) regulação de câncer com o uso de compostos e/ou dieta naturais
EA201990337A1 (ru) Композиция для местного применения с противогрибковой активностью
BR112016007462A2 (pt) fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite
CL2020000918A1 (es) Composición sólida.
UY36248A (es) ?una dispersión a base de agua o aceite, formulaciones y método para prepararlas, y uso de las dispersiones o formulaciones?.
RU2014130012A (ru) Композиции, содержащие экстракт malva neglecta
CY1123942T1 (el) Συνθεσεις ωμεγα-3 λιπαρων οξεων για τη θεραπεια ασθενειων που επιφερουν βλαβη στο νευρικο συστημα
CY1121403T1 (el) Μορφοποιηση για προσωπικη υγιεινη
CL2019001550A1 (es) Fenytoina tópica para uso en el tratamiento del dolor neuropático periférico.
AR112291A1 (es) Composición para su uso en la prevención y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncológico
AR112466A1 (es) Complejo cosmético para la hidratación bioactiva, composición cosmética, uso y método
HRP20191989T1 (hr) Farmaceutski pripravak za uporabu u povećanju trofizma sluznice nosa
GT201400146A (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
AR101274A1 (es) Composición para uso en la prevención y tratamiento de rinitis alérgica
AR103718A1 (es) Mezclas de aceite, procedimientos para su preparación y sus usos en fórmulas
BR112017015452A2 (pt) formulação farmacêutica
ECSP13012988A (es) Derivados de tienopirimidina (2,3-d) y su uso para tratar arritmia

Legal Events

Date Code Title Description
FB Suspension of granting procedure